Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Net Margin (2016 - 2025)

Historic Net Margin for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Q3 2025 value amounting to 23.5%.

  • Cumberland Pharmaceuticals' Net Margin fell 65900.0% to 23.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.09%, marking a year-over-year increase of 213900.0%. This contributed to the annual value of 17.02% for FY2024, which is 10100.0% down from last year.
  • Cumberland Pharmaceuticals' Net Margin amounted to 23.5% in Q3 2025, which was down 65900.0% from 6.78% recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Net Margin peaked at 10.66% during Q1 2025, and registered a low of 67.38% during Q4 2023.
  • Its 4-year average for Net Margin is 8.74%, with a median of 6.78% in 2025.
  • Data for Cumberland Pharmaceuticals' Net Margin shows a peak YoY increase of 491600bps (in 2024) and a maximum YoY decrease of -242600bps (in 2024) over the last 5 years.
  • Cumberland Pharmaceuticals' Net Margin (Quarter) stood at 6.05% in 2021, then crashed by -1214bps to 67.38% in 2023, then soared by 73bps to 18.22% in 2024, then decreased by -29bps to 23.5% in 2025.
  • Its last three reported values are 23.5% in Q3 2025, 6.78% for Q2 2025, and 10.66% during Q1 2025.